AB001

DRUG2 trials

Sponsors

Frontier Biotechnologies Inc., ARTBIO Inc.

Conditions

Chronic Low Back PainMetastatic Castrate Resistant Prostate Cancer (mCRPC)Prostate Cancer (CRPC)

Phase 1

Tolerability, Safety and Pharmacokinetics of a Topical AB001 Patch in Healthy Subjects

CompletedNCT03997734

Frontier Biotechnologies Inc.Chronic Low Back Pain

Start: 2019-06-24End: 2019-11-11Updated: 2020-03-30

Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Active, not recruitingNCT07214961

ARTBIO Inc.Metastatic Castrate Resistant Prostate Cancer (mCRPC), Prostate Cancer (CRPC)

Start: 2025-11-03End: 2028-11-03Target: 80Updated: 2026-04-07